It might go down and you make a buck or it can still go higher. This in no way is a P&D. The company is being bought out by Allergan for about $1.7 billion.
Allergan's offer on Tuesday of $28.35 upfront per Tobira share is a whopping 500 percent premium to the stock's close on Monday, which had given Tobira a market capitalization of about $89 million. Tobira shareholders could receive up to $49.84 per share, contingent on the company achieving certain milestones.
News 
Market Data 
Discover 
